|
SNAPC5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.86197757002083E-14 |
| Normal-vs-Stage2 |
1.649550E-04 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62847513252018E-12 |
| Stage1-vs-Stage2 |
1.141630E-01 |
| Stage1-vs-Stage3 |
1.217830E-02 |
| Stage1-vs-Stage4 |
2.278800E-03 |
| Stage2-vs-Stage3 |
4.280000E-03 |
| Stage2-vs-Stage4 |
1.398960E-03 |
| Stage3-vs-Stage4 |
5.437400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.59679999999618E-05 |
| Normal-vs-Asian |
8.78469963438988E-10 |
| Caucasian-vs-AfricanAmerican |
1.903850E-01 |
| Caucasian-vs-Asian |
9.634800E-01 |
| AfricanAmerican-vs-Asian |
2.873400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.56541446472147E-14 |
| Normal-vs-Female |
1.62836411021772E-12 |
| Male-vs-Female |
1.748570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64657176782157E-12 |
| Normal-vs-Age(41-60Yrs) |
7.60724816473157E-13 |
| Normal-vs-Age(61-80Yrs) |
1.37849731629558E-11 |
| Normal-vs-Age(81-100Yrs) |
8.12690000000504E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.572400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.554800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.544400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.458600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.764600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.149200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.218530E-04 |
| Classical-VS-Follicular |
4.958000E-03 |
| Classical-VS-Other |
5.156000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.96039999958531E-07 |
| Tall-VS-Other |
2.877800E-01 |
| Tall-VS-Normal |
2.22044604925031E-16 |
| Follicular-VS-Other |
1.853770E-01 |
| Follicular-VS-Normal |
2.32229999999056E-05 |
| Other-VS-Normal |
2.809900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.92359486514715E-11 |
| Normal-vs-N1 |
2.44249065417534E-15 |
| N0-vs-N1 |
1.042070E-04 |
|
|
